Oncodesign innovation vector.

 
  2. Home
  3. Scientific publications
  4. Posters
  5. Posters 2017

Posters 2017

AACR 2017 - IMODI initiative : a novel holistic and integrative approach with patient-derived tumor models against pancreatic cancer

Ariana Pharmaceuticals, Paris; Biofortis, Saint-Herblain; CTI-BIOTECH, Meyzieu;Modul-Bio, Marseille; Oncodesign, Dijon ; OncoMedics, Limoges; Ipsen Innovation, Les Ulis; Pierre Fabre Research Institut, St-Julien-en-Genevois; Sanofi, Vitry-sur-Seine; Centre Léon Bérard, Lyon; INSERM U1068, Marseille; Synergie Lyon Cancer, Lyon; CIPREVO, Antony (France)

DOWNLOAD

AACR 2017 - Antitumor activity of CMP-001 (TLR9 agonist) alone or combined with immune modulators in syngeneic tumor modelsdels of brain tumors : morphological and vascular characteristics

Oncodesign, Dijon (France) ; Checkmate Pharmaceuticals, Cambridge, MA (USA)

DOWNLOAD

AACR 2017 - Overcoming PD-1 targeting antibody resistance using combination strategieshuman lung tumors using DCE-MRI and FLOOD MRI

Oncodesign, Dijon (France)

DOWNLOAD

AACR 2017 - Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

Oncodesign, Dijon, Pharmimage, Dijon, Unité INSERM 930, Tours, CERRP, Tours, Cyclopharma Laboratories, Saint-Beauzire, CEA, I2BM, LDM-TEP, Caen (France)

DOWNLOAD